Literature DB >> 12782432

Cancer pain management and the JCAHO's pain standards: an institutional challenge.

Marlene Zichi Cohen1, Mary K Easley, Coni Ellis, Beverly Hughes, Kristin Ownby, Beverly Green Rashad, Mari Rude, Ellen Taft, Joycelyn Bailey Westbrooks.   

Abstract

Unrelieved pain is a major medical problem. In response to this problem, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) launched new standards for pain management in 1999. A review was conducted in five hospitals of 117 charts of 80 inpatients and 37 outpatients with cancer who had pain documented in their medical records to determine whether application of these JCAHO standards was documented. Pain assessment and management were not documented for most patients. Pain intensity was noted for 57% of outpatients and 53% of inpatients. When pain was documented, treatment was noted in 86% of outpatients' charts and 89% of inpatients' charts. Of those patients with documented pain, reassessment after treatment was reported in 34% of the outpatient charts and 44% of the inpatient charts. Work to properly manage cancer pain needs to continue, and the JCAHO standards provide a mechanism to evaluate practice documentation in order to improve care.

Entities:  

Mesh:

Year:  2003        PMID: 12782432     DOI: 10.1016/s0885-3924(03)00068-x

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  34 in total

1.  Assessing and treating pain in hospices: current state of evidence-based practices.

Authors:  Keela Herr; Marita Titler; Perry Fine; Sara Sanders; Joe Cavanaugh; John Swegle; Chris Forcucci; Xiongwen Tang
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

2.  Efficacy of pain education in cancer patients: a meta-analysis of randomized controlled trials.

Authors:  Hyun Jung Jho; Seung-Kwon Myung; Yoon-Jung Chang; Dae-Hyun Kim; Doo Heun Ko
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

3.  Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: a multi-center prospective randomized controlled study.

Authors:  Chang-ming Chen; Li-zhu Lin; En-xin Zhang
Journal:  Chin J Integr Med       Date:  2014-06-28       Impact factor: 1.978

4.  Pain intensity assessment by bedside nurses and palliative care consultants: a retrospective study.

Authors:  Eduardo Bruera; Jie S Willey; Patricia A Ewert-Flannagan; Mary K Cline; Guddi Kaur; Loren Shen; Tao Zhang; J Lynn Palmer
Journal:  Support Care Cancer       Date:  2004-10-06       Impact factor: 3.603

5.  Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.

Authors:  Masashi Ishihara; Hirotoshi Iihara; Shinji Okayasu; Koji Yasuda; Katsuhiko Matsuura; Masumi Suzui; Yoshinori Itoh
Journal:  Support Care Cancer       Date:  2009-11-18       Impact factor: 3.603

6.  Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting?

Authors:  Y Aldairy; P L Nguyen; A Jatoi
Journal:  Eur J Cancer Care (Engl)       Date:  2011-01       Impact factor: 2.520

Review 7.  Cancer pain: perspectives of a medical oncologist.

Authors:  Keith D Eaton; Deborah A Frieze
Journal:  Curr Pain Headache Rep       Date:  2008-08

8.  Quality of life in cancer patients with pain in beijing.

Authors:  Ping Yang; Li-Qiu Sun; Dong Pang; Yue Ding
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

9.  Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings.

Authors:  Donna S Zhukovsky; Cathy L Rozmus; Rhonda S Robert; Eduardo Bruera; Robert J Wells; Gary B Chisholm; Julio A Allo; Marlene Z Cohen
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

10.  Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group.

Authors:  G Apolone; O Corli; A Caraceni; E Negri; S Deandrea; M Montanari; M T Greco
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.